222 related articles for article (PubMed ID: 31100208)
1. Medication taking behaviors in patients taking warfarin versus direct oral anticoagulants: A systematic review.
Mohan A; Wanat MA; Abughosh SM
Expert Rev Cardiovasc Ther; 2019 Jun; 17(6):427-434. PubMed ID: 31100208
[No Abstract] [Full Text] [Related]
2. A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation.
Obamiro KO; Chalmers L; Bereznicki LR
Am J Cardiovasc Drugs; 2016 Oct; 16(5):349-63. PubMed ID: 27262433
[TBL] [Abstract][Full Text] [Related]
3. [New direct oral oral anticoagulants (DOACs) - indications of DOACs].
Darius H
Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Mar; 49(3):182-90; quiz 191. PubMed ID: 24711238
[TBL] [Abstract][Full Text] [Related]
4. Self-reported adherence to direct oral anticoagulants versus warfarin therapy in a specialized thrombosis service-a cross-sectional study of patients in a Canadian Health Region.
Bonsu KO; Young SW; Lee T; Nguyen HV; Chitsike RS
Eur J Clin Pharmacol; 2023 Jan; 79(1):117-125. PubMed ID: 36399203
[TBL] [Abstract][Full Text] [Related]
5. Persistence and outcomes of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation.
Wu S; Xie S; Xu Y; Que D; Yau TO; Wang L; Huang Y
J Clin Nurs; 2019 May; 28(9-10):1839-1846. PubMed ID: 30667111
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
7. Factors Affecting Patients' Perception On, and Adherence To, Anticoagulant Therapy: Anticipating the Role of Direct Oral Anticoagulants.
Pandya EY; Bajorek B
Patient; 2017 Apr; 10(2):163-185. PubMed ID: 27438598
[TBL] [Abstract][Full Text] [Related]
8. Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.
Ozaki AF; Choi AS; Le QT; Ko DT; Han JK; Park SS; Jackevicius CA
Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005969. PubMed ID: 32148102
[TBL] [Abstract][Full Text] [Related]
9. Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation.
Forslund T; Wettermark B; Hjemdahl P
Eur J Clin Pharmacol; 2016 Mar; 72(3):329-38. PubMed ID: 26613954
[TBL] [Abstract][Full Text] [Related]
10. Risk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies.
Deitelzweig S; Farmer C; Luo X; Vo L; Li X; Hamilton M; Horblyuk R; Ashaye A
Curr Med Res Opin; 2017 Sep; 33(9):1583-1594. PubMed ID: 28644048
[TBL] [Abstract][Full Text] [Related]
11. Intracranial Hemorrhage in Deep Vein Thrombosis/Pulmonary Embolus Patients Without Atrial Fibrillation.
Lamsam L; Sussman ES; Iyer AK; Bhambhvani HP; Han SS; Skirboll S; Ratliff JK
Stroke; 2018 Aug; 49(8):1866-1871. PubMed ID: 29991654
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Patient Adherence to Direct Oral Anticoagulant vs Warfarin Therapy.
Patel SI; Cherington C; Scherber R; Barr K; McLemore R; Morisky DE; Cha S; Mookadam F; Shamoun F
J Am Osteopath Assoc; 2017 Jan; 117(1):7-15. PubMed ID: 28055097
[TBL] [Abstract][Full Text] [Related]
13. Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation.
Manzoor BS; Lee TA; Sharp LK; Walton SM; Galanter WL; Nutescu EA
Pharmacotherapy; 2017 Oct; 37(10):1221-1230. PubMed ID: 28730619
[TBL] [Abstract][Full Text] [Related]
14. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
15. Ensuring medication adherence with direct oral anticoagulant drugs: lessons from adherence with vitamin K antagonists (VKAs).
Di Minno A; Spadarella G; Tufano A; Prisco D; Di Minno G
Thromb Res; 2014 May; 133(5):699-704. PubMed ID: 24525314
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
Am J Cardiol; 2016 Jul; 118(2):210-4. PubMed ID: 27236255
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey.
Obamiro KO; Chalmers L; Lee K; Bereznicki BJ; Bereznicki LRE
Int J Clin Pract; 2018 Mar; 72(3):e13072. PubMed ID: 29457323
[TBL] [Abstract][Full Text] [Related]
18. Prescription Patterns of Non-Vitamin K Oral Anticoagulants Across Indications and Factors Associated with Their Increased Prescribing in Atrial Fibrillation Between 2012-2015: A Study from the Norwegian Prescription Database.
Urbaniak AM; Strøm BO; Krontveit R; Svanqvist KH
Drugs Aging; 2017 Aug; 34(8):635-645. PubMed ID: 28710707
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis, prognosis and therapeutic management of acute pulmonary embolism.
Tapson VF
Hosp Pract (1995); 2016 Aug; 44(3):164-72. PubMed ID: 27450108
[TBL] [Abstract][Full Text] [Related]
20. Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015.
Kjerpeseth LJ; Ellekjær H; Selmer R; Ariansen I; Furu K; Skovlund E
Eur J Clin Pharmacol; 2017 Nov; 73(11):1417-1425. PubMed ID: 28735494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
